Literature DB >> 17581402

The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix.

Jalil Hariri1, Anne Øster.   

Abstract

The immunohistochemical expression of p16 in formalin-fixed and paraffin-embedded histological sections was evaluated in a retrospective study comprising a low-grade group of 100 cases of cervical intraepithelial neoplasia (CIN) 1, a high-grade group of 50 cases of CIN 2 to 3, and a benign group of 50 cases of normal tissue or benign lesions in the uterine cervix. The cases were consecutive within each group and had a minimum follow-up period of 5 years. Positive reaction for p16 was detected in all cases in the high-grade group and in only 3 cases in the benign group. In the low-grade group, a total of 9 cases had to be excluded. The remaining 91 cases in the low-grade group showed positive reaction for p16 in 65 cases (71%), including 23 cases that progressed to a high-grade lesion, 36 cases that revealed normal cytological and/or histological picture during the follow-up period, and 6 cases that persisted as CIN 1. A total of 26 cases (29%) in the low-grade group showed negative reaction for p16. All but one of these p16 negative cases in the low-grade group had a benign or normal outcome. This case showed a high-grade lesion in the follow-up period and was probably a high-grade lesion from the beginning and so underestimated as CIN 1. These results reveal that the negative predictive value of p16 to predict the outcome of the cases of CIN 1 is as high as 96%, which strongly suggest an important role of p16 in the assessment of this type of lesion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581402     DOI: 10.1097/01.pgp.0000236942.51840.56

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  17 in total

1.  MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.

Authors:  Alvaro P Pinto; Christopher P Crum; Michelle S Hirsch
Journal:  Diagn Histopathol (Oxf)       Date:  2010-10-01

2.  mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.

Authors:  Marta Del Pino; Cecilia Svanholm-Barrie; Aureli Torné; Lorena Marimon; Jina Gaber; Amaia Sagasta; David H Persing; Jaume Ordi
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

3.  Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease.

Authors:  Ankica Lukic; Giorgio Sbenaglia; Elisabetta Carico; Matilde DI Properzio; Enrico Giarnieri; Antonio Frega; Flavia Nobili; Massimo Moscarini; Maria Rosaria Giovagnoli
Journal:  Exp Ther Med       Date:  2011-07-01       Impact factor: 2.447

4.  p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.

Authors:  Petr Skapa; Helena Robova; Lukas Rob; Josef Zamecnik
Journal:  Pathol Oncol Res       Date:  2013-05-18       Impact factor: 3.201

5.  RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

Authors:  Paola Cattani; Alessia Siddu; Sara D'Onghia; Simona Marchetti; Rosaria Santangelo; Valerio G Vellone; Gian Franco Zannoni; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

Review 6.  p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.

Authors:  I Tsoumpou; M Arbyn; M Kyrgiou; N Wentzensen; G Koliopoulos; P Martin-Hirsch; V Malamou-Mitsi; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2009-03-03       Impact factor: 12.111

7.  Triple non-invasive diagnostic test for exclusion of common bile ducts stones before laparoscopic cholecystectomy.

Authors:  Bahram Pourseidi; Amir Khorram-Manesh
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

Review 8.  Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Authors:  Kate Cuschieri; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

9.  ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer.

Authors:  Li Ding; Xian-Jin Zou; Jin-E Ao; Ai-Xiang Yao; Lan Cai
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

10.  p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.

Authors:  Amaia Sagasta; Paola Castillo; Adela Saco; Aureli Torné; Roser Esteve; Lorena Marimon; Jaume Ordi; Marta Del Pino
Journal:  Mod Pathol       Date:  2015-11-06       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.